Registered number
10203677
Nayak Kumble Medical Services Limited
Filleted Accounts
31 March 2024
Nayak Kumble Medical Services Limited
Registered number: 10203677
Balance Sheet
as at 31 March 2024
Notes 2024 2023
£ £
Fixed assets
Tangible assets 3 830 1,037
Investments 4 - 15,000
830 16,037
Current assets
Debtors 5 51,611 27,234
Cash at bank and in hand 487,252 418,117
538,863 445,351
Creditors: amounts falling due within one year 6 (49,234) (44,429)
Net current assets 489,629 400,922
Net assets 490,459 416,959
Capital and reserves
Called up share capital 2 2
Profit and loss account 490,457 416,957
Shareholders' funds 490,459 416,959
The directors are satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The members have not required the company to obtain an audit in accordance with section 476 of the Act.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
Dr Gajanana Kini Kumble
Director
Approved by the board on 15 November 2024
Nayak Kumble Medical Services Limited
Notes to the Accounts
for the year ended 31 March 2024
1 Accounting policies
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the rendering of services. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Tangible fixed assets
Tangible fixed assets are measured at cost less accumulative depreciation and any accumulative impairment losses. Depreciation is provided on all tangible fixed assets, other than freehold land, at rates calculated to write off the cost, less estimated residual value, of each asset evenly over its expected useful life, as follows:
Freehold buildings over 50 years
Leasehold land and buildings over the lease term
Plant and machinery over 5 years
Fixtures, fittings, tools and equipment over 5 years
Investments
Investments in subsidiaries, associates and joint ventures are measured at cost less any accumulated impairment losses. Listed investments are measured at fair value. Unlisted investments are measured at fair value unless the value cannot be measured reliably, in which case they are measured at cost less any accumulated impairment losses. Changes in fair value are included in the profit and loss account.
Debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
Taxation
A current tax liability is recognised for the tax payable on the taxable profit of the current and past periods. A current tax asset is recognised in respect of a tax loss that can be carried back to recover tax paid in a previous period. Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Provisions
Provisions (ie liabilities of uncertain timing or amount) are recognised when there is an obligation at the reporting date as a result of a past event, it is probable that economic benefit will be transferred to settle the obligation and the amount of the obligation can be estimated reliably.
2 Employees 2024 2023
Number Number
Average number of persons employed by the company 2 2
3 Tangible fixed assets
Plant and machinery etc
£
Cost
At 1 April 2023 1,427
At 31 March 2024 1,427
Depreciation
At 1 April 2023 390
Charge for the year 207
At 31 March 2024 597
Net book value
At 31 March 2024 830
At 31 March 2023 1,037
4 Investments
Other
investments
£
Cost
At 1 April 2023 15,000
Written off as unrealised (15,000)
At 31 March 2024 -
Historical cost
At 1 April 2023 15,000
The Other investments are not expected to be returned as the company gone into liquidation and hence written off during the year.
5 Debtors 2024 2023
£ £
Other debtors 51,611 27,234
6 Creditors: amounts falling due within one year 2024 2023
£ £
Taxation and social security costs 47,514 43,074
Other creditors 1,720 1,355
49,234 44,429
7 Loans to directors
Description and conditions B/fwd Paid Repaid C/fwd
£ £ £ £
Dr Gajanana Kini Kumble
Directors loan 2,000 12,000 (2,000) 12,000
Dr Sonali Sheshgiri Nayak
Directors loan - 20,000 - 20,000
2,000 32,000 (2,000) 32,000
The Other debtors include loans to directors which, have been repaid in full before signing these accounts.
8 Other information
Nayak Kumble Medical Services Limited is a private company limited by shares and incorporated in England. Its registered office is:
59 Blackthorn Road
Hazel Grove
Stockport
SK7 5EL
Nayak Kumble Medical Services Limited 10203677 false 2023-04-01 2024-03-31 2024-03-31 VT Final Accounts July 2024 Dr Gajanana Kini Kumble No description of principal activity 10203677 2022-04-01 2023-03-31 10203677 core:WithinOneYear 2023-03-31 10203677 core:ShareCapital 2023-03-31 10203677 core:RetainedEarningsAccumulatedLosses 2023-03-31 10203677 2023-04-01 2024-03-31 10203677 bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 10203677 bus:AuditExemptWithAccountantsReport 2023-04-01 2024-03-31 10203677 bus:Director40 2023-04-01 2024-03-31 10203677 1 2023-04-01 2024-03-31 10203677 2 2023-04-01 2024-03-31 10203677 core:PlantMachinery 2023-04-01 2024-03-31 10203677 bus:Director1 2023-04-01 2024-03-31 10203677 bus:Director1 1 2023-04-01 2024-03-31 10203677 bus:Director2 2023-04-01 2024-03-31 10203677 bus:Director2 1 2023-04-01 2024-03-31 10203677 countries:England 2023-04-01 2024-03-31 10203677 bus:FRS102 2023-04-01 2024-03-31 10203677 bus:FilletedAccounts 2023-04-01 2024-03-31 10203677 2024-03-31 10203677 core:WithinOneYear 2024-03-31 10203677 core:ShareCapital 2024-03-31 10203677 core:RetainedEarningsAccumulatedLosses 2024-03-31 10203677 core:PlantMachinery 2024-03-31 10203677 core:DisposalsRepaymentsInvestments 2024-03-31 10203677 bus:Director1 1 2024-03-31 10203677 bus:Director2 1 2024-03-31 10203677 2023-03-31 10203677 core:PlantMachinery 2023-03-31 10203677 bus:Director1 1 2023-03-31 10203677 bus:Director2 1 2023-03-31 iso4217:GBP xbrli:pure